tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SBMFF Stock Latest News

Sino Biopharmaceutical’s Innovative Cancer Drug TQB3142 Gains NMPA Approval for Clinical Trials
Company AnnouncementsSino Biopharmaceutical’s Innovative Cancer Drug TQB3142 Gains NMPA Approval for Clinical Trials
5d ago
Sino Biopharmaceutical’s TQB3122 IND Application Accepted by NMPA
PremiumCompany Announcements
Sino Biopharmaceutical’s TQB3122 IND Application Accepted by NMPA
6d ago
Sino Biopharmaceutical’s Phase II Trial for Innovative Cancer Drug Approved
PremiumCompany Announcements
Sino Biopharmaceutical’s Phase II Trial for Innovative Cancer Drug Approved
10d ago
Sino Biopharmaceutical’s Rovadicitinib Gains Breakthrough Designation for cGVHD
PremiumCompany Announcements
Sino Biopharmaceutical’s Rovadicitinib Gains Breakthrough Designation for cGVHD
11d ago
Sino Biopharmaceutical’s TQC3302 Receives Clinical Trial Approval
PremiumCompany Announcements
Sino Biopharmaceutical’s TQC3302 Receives Clinical Trial Approval
12d ago
Sino Biopharmaceutical: Innovation-Driven Growth and Strong Financials Justify Buy Rating
PremiumRatingsSino Biopharmaceutical: Innovation-Driven Growth and Strong Financials Justify Buy Rating
16d ago
Sino Biopharmaceutical Schedules Board Meeting for Interim Results and Dividend Consideration
Premium
Company Announcements
Sino Biopharmaceutical Schedules Board Meeting for Interim Results and Dividend Consideration
16d ago
Sino Biopharmaceutical to Receive $300 Million Milestone Payment from Merck Collaboration
Premium
Company Announcements
Sino Biopharmaceutical to Receive $300 Million Milestone Payment from Merck Collaboration
18d ago
Sino Biopharmaceutical Gains FDA Approval for Innovative Cancer Drug
PremiumCompany Announcements
Sino Biopharmaceutical Gains FDA Approval for Innovative Cancer Drug
24d ago
Sino Biopharmaceutical Expands with LaNova Medicines Acquisition Update
PremiumCompany Announcements
Sino Biopharmaceutical Expands with LaNova Medicines Acquisition Update
26d ago
Sino Biopharmaceutical Advances TQB6411 in Phase I Clinical Trials
PremiumCompany Announcements
Sino Biopharmaceutical Advances TQB6411 in Phase I Clinical Trials
26d ago
Sino Biopharmaceutical Acquires Full Stake in LaNova Medicines
PremiumCompany Announcements
Sino Biopharmaceutical Acquires Full Stake in LaNova Medicines
1M ago
Sino Biopharmaceutical’s New Breast Cancer Treatment Gains Regulatory Acceptance
PremiumCompany AnnouncementsSino Biopharmaceutical’s New Breast Cancer Treatment Gains Regulatory Acceptance
1M ago
Sino Biopharmaceutical’s Anqixin® Approved for Marketing in China
Premium
Company Announcements
Sino Biopharmaceutical’s Anqixin® Approved for Marketing in China
2M ago
Sino Biopharmaceutical’s Anlotinib Combo Approved for Soft Tissue Sarcoma
Premium
Company Announcements
Sino Biopharmaceutical’s Anlotinib Combo Approved for Soft Tissue Sarcoma
2M ago
Sino Biopharmaceutical’s LM-108 Gains Breakthrough Therapy Status in China
PremiumCompany Announcements
Sino Biopharmaceutical’s LM-108 Gains Breakthrough Therapy Status in China
2M ago
Sino Biopharmaceutical Reports Breakthrough in GVHD Treatment with Rovadicitinib
PremiumCompany Announcements
Sino Biopharmaceutical Reports Breakthrough in GVHD Treatment with Rovadicitinib
2M ago
Sino Biopharmaceutical’s TDI01 Gains Breakthrough Therapy Designation
PremiumCompany Announcements
Sino Biopharmaceutical’s TDI01 Gains Breakthrough Therapy Designation
2M ago
Sino Biopharmaceutical Advances Innovation-Driven Strategy with New Product Launches
PremiumCompany Announcements
Sino Biopharmaceutical Advances Innovation-Driven Strategy with New Product Launches
2M ago
Sino Biopharmaceutical Secures Shareholder Approval for Key Resolutions at AGM
PremiumCompany AnnouncementsSino Biopharmaceutical Secures Shareholder Approval for Key Resolutions at AGM
2M ago
Sino Biopharmaceutical Advances Phase III Study for Promising Pancreatic Cancer Drug
Premium
Company Announcements
Sino Biopharmaceutical Advances Phase III Study for Promising Pancreatic Cancer Drug
2M ago
Sino Biopharmaceutical’s TQC3721 Receives Phase III Clinical Study Approval
Premium
Company Announcements
Sino Biopharmaceutical’s TQC3721 Receives Phase III Clinical Study Approval
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >